nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—female reproductive system—cervical cancer	0.0483	0.257	CbGeAlD
Octreotide—SSTR4—female gonad—cervical cancer	0.044	0.233	CbGeAlD
Octreotide—SSTR2—renal system—cervical cancer	0.0331	0.176	CbGeAlD
Octreotide—SSTR1—female reproductive system—cervical cancer	0.0311	0.165	CbGeAlD
Octreotide—MPO—C-MYB transcription factor network—PIAS3—cervical cancer	0.027	0.0481	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0198	0.0353	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—TAAR6—cervical cancer	0.0151	0.0269	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.015	0.0268	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0144	0.0257	CbGpPWpGaD
Octreotide—Intestinal obstruction—Topotecan—cervical cancer	0.0139	0.0556	CcSEcCtD
Octreotide—Neuralgia—Topotecan—cervical cancer	0.0136	0.0545	CcSEcCtD
Octreotide—MPO—epithelium—cervical cancer	0.0135	0.0717	CbGeAlD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0128	0.0228	CbGpPWpGaD
Octreotide—MPO—renal system—cervical cancer	0.0125	0.0665	CbGeAlD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0118	0.021	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—WNT2—cervical cancer	0.0118	0.021	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—TAAR6—cervical cancer	0.0115	0.0204	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—TAAR6—cervical cancer	0.011	0.0195	CbGpPWpGaD
Octreotide—Extravasation—Topotecan—cervical cancer	0.0108	0.0434	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0104	0.0416	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.0101	0.018	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—TAAR6—cervical cancer	0.00974	0.0173	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—TAAR6—cervical cancer	0.00899	0.016	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—WNT2—cervical cancer	0.00894	0.0159	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—WNT5A—cervical cancer	0.00894	0.0159	CbGpPWpGaD
Octreotide—Neuropathy—Topotecan—cervical cancer	0.00888	0.0356	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—WNT2—cervical cancer	0.00857	0.0153	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00857	0.0153	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—TAAR6—cervical cancer	0.00854	0.0152	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—CD4—cervical cancer	0.00838	0.0149	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—MTHFR—cervical cancer	0.00821	0.0146	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—TAAR6—cervical cancer	0.00776	0.0138	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—HES1—cervical cancer	0.00771	0.0137	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—WNT2—cervical cancer	0.0076	0.0135	CbGpPWpGaD
Octreotide—Anaphylactoid reaction—Topotecan—cervical cancer	0.0071	0.0284	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—WNT2—cervical cancer	0.00702	0.0125	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00702	0.0125	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—WNT5A—cervical cancer	0.00678	0.0121	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00652	0.0116	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—WNT5A—cervical cancer	0.0065	0.0116	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—STAT3—cervical cancer	0.00649	0.0116	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—TAAR6—cervical cancer	0.00647	0.0115	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—TAAR6—cervical cancer	0.00621	0.011	CbGpPWpGaD
Octreotide—Cramp muscle—Topotecan—cervical cancer	0.00618	0.0248	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—WNT2—cervical cancer	0.00606	0.0108	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—TAAR6—cervical cancer	0.00588	0.0105	CbGpPWpGaD
Octreotide—MPO—lymph node—cervical cancer	0.00586	0.0311	CbGeAlD
Octreotide—SSTR4—GPCR downstream signaling—AKAP13—cervical cancer	0.00585	0.0104	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—WNT5A—cervical cancer	0.00576	0.0103	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—TAAR6—cervical cancer	0.00564	0.01	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—TAAR6—cervical cancer	0.0055	0.0098	CbGpPWpGaD
Octreotide—Weight increased—Topotecan—cervical cancer	0.0054	0.0216	CcSEcCtD
Octreotide—Pneumonia—Topotecan—cervical cancer	0.00532	0.0213	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—WNT5A—cervical cancer	0.00532	0.00946	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AKAP13—cervical cancer	0.00532	0.00946	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Topotecan—cervical cancer	0.00519	0.0208	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—TAAR6—cervical cancer	0.00508	0.00904	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Topotecan—cervical cancer	0.00501	0.02	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—TAAR6—cervical cancer	0.005	0.0089	CbGpPWpGaD
Octreotide—Epistaxis—Topotecan—cervical cancer	0.00499	0.02	CcSEcCtD
Octreotide—Rhinitis—Topotecan—cervical cancer	0.00476	0.0191	CcSEcCtD
Octreotide—Hypoaesthesia—Topotecan—cervical cancer	0.00473	0.0189	CcSEcCtD
Octreotide—Pharyngitis—Topotecan—cervical cancer	0.00472	0.0189	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—TAAR6—cervical cancer	0.00461	0.00821	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—WNT5A—cervical cancer	0.00459	0.00817	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—WNT2—cervical cancer	0.00459	0.00817	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TAAR6—cervical cancer	0.00458	0.00816	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00446	0.00794	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AKAP13—cervical cancer	0.00444	0.0079	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—WNT2—cervical cancer	0.0044	0.00783	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—CD4—cervical cancer	0.00435	0.00774	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.0043	0.00765	CbGpPWpGaD
Octreotide—Immune system disorder—Topotecan—cervical cancer	0.00429	0.0172	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—AKAP13—cervical cancer	0.00425	0.00757	CbGpPWpGaD
Octreotide—Alopecia—Topotecan—cervical cancer	0.0042	0.0168	CcSEcCtD
Octreotide—Malnutrition—Topotecan—cervical cancer	0.00414	0.0166	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—AKAP13—cervical cancer	0.00403	0.00717	CbGpPWpGaD
Octreotide—Back pain—Topotecan—cervical cancer	0.004	0.016	CcSEcCtD
Octreotide—Muscle spasms—Topotecan—cervical cancer	0.00398	0.0159	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—WNT2—cervical cancer	0.0039	0.00694	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AKAP13—cervical cancer	0.00386	0.00687	CbGpPWpGaD
Octreotide—Ill-defined disorder—Topotecan—cervical cancer	0.00384	0.0154	CcSEcCtD
Octreotide—Anaemia—Topotecan—cervical cancer	0.00382	0.0153	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—AKAP13—cervical cancer	0.00377	0.00671	CbGpPWpGaD
Octreotide—Malaise—Topotecan—cervical cancer	0.00373	0.0149	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00365	0.0065	CbGpPWpGaD
Octreotide—Cough—Topotecan—cervical cancer	0.00361	0.0144	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—WNT2—cervical cancer	0.0036	0.00641	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—WNT2—cervical cancer	0.00358	0.00637	CbGpPWpGaD
Octreotide—Chest pain—Topotecan—cervical cancer	0.00352	0.0141	CcSEcCtD
Octreotide—Myalgia—Topotecan—cervical cancer	0.00352	0.0141	CcSEcCtD
Octreotide—Arthralgia—Topotecan—cervical cancer	0.00352	0.0141	CcSEcCtD
Octreotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00352	0.00626	CbGpPWpGaD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0035	0.014	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—AKAP13—cervical cancer	0.00348	0.0062	CbGpPWpGaD
Octreotide—Discomfort—Topotecan—cervical cancer	0.00348	0.0139	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—WNT5A—cervical cancer	0.00348	0.00619	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TAAR6—cervical cancer	0.00347	0.00618	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AKAP13—cervical cancer	0.00343	0.0061	CbGpPWpGaD
Octreotide—Anaphylactic shock—Topotecan—cervical cancer	0.00338	0.0135	CcSEcCtD
Octreotide—Infection—Topotecan—cervical cancer	0.00335	0.0134	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—WNT5A—cervical cancer	0.00333	0.00593	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TAAR6—cervical cancer	0.00333	0.00593	CbGpPWpGaD
Octreotide—Nervous system disorder—Topotecan—cervical cancer	0.00331	0.0133	CcSEcCtD
Octreotide—Thrombocytopenia—Topotecan—cervical cancer	0.0033	0.0132	CcSEcCtD
Octreotide—Skin disorder—Topotecan—cervical cancer	0.00328	0.0131	CcSEcCtD
Octreotide—Hyperhidrosis—Topotecan—cervical cancer	0.00326	0.0131	CcSEcCtD
Octreotide—Anorexia—Topotecan—cervical cancer	0.00322	0.0129	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—AKAP13—cervical cancer	0.00316	0.00563	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AKAP13—cervical cancer	0.00314	0.00559	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—cervical cancer	0.00312	0.00555	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00308	0.0123	CcSEcCtD
Octreotide—Paraesthesia—Topotecan—cervical cancer	0.00303	0.0121	CcSEcCtD
Octreotide—Dyspnoea—Topotecan—cervical cancer	0.00301	0.012	CcSEcCtD
Octreotide—Dyspepsia—Topotecan—cervical cancer	0.00297	0.0119	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—WNT5A—cervical cancer	0.00296	0.00526	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TAAR6—cervical cancer	0.00295	0.00526	CbGpPWpGaD
Octreotide—Decreased appetite—Topotecan—cervical cancer	0.00293	0.0117	CcSEcCtD
Octreotide—Gastrointestinal disorder—Topotecan—cervical cancer	0.00291	0.0117	CcSEcCtD
Octreotide—Fatigue—Topotecan—cervical cancer	0.00291	0.0116	CcSEcCtD
Octreotide—Pain—Topotecan—cervical cancer	0.00289	0.0116	CcSEcCtD
Octreotide—Constipation—Topotecan—cervical cancer	0.00289	0.0116	CcSEcCtD
Octreotide—Feeling abnormal—Topotecan—cervical cancer	0.00278	0.0111	CcSEcCtD
Octreotide—Gastrointestinal pain—Topotecan—cervical cancer	0.00276	0.011	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—WNT5A—cervical cancer	0.00273	0.00486	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TAAR6—cervical cancer	0.00273	0.00485	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—WNT2—cervical cancer	0.00271	0.00482	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—WNT5A—cervical cancer	0.00271	0.00482	CbGpPWpGaD
Octreotide—Urticaria—Topotecan—cervical cancer	0.00268	0.0107	CcSEcCtD
Octreotide—Body temperature increased—Topotecan—cervical cancer	0.00267	0.0107	CcSEcCtD
Octreotide—Abdominal pain—Topotecan—cervical cancer	0.00267	0.0107	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—WNT2—cervical cancer	0.0026	0.00463	CbGpPWpGaD
Octreotide—Hypersensitivity—Topotecan—cervical cancer	0.00249	0.00995	CcSEcCtD
Octreotide—Asthenia—Topotecan—cervical cancer	0.00242	0.00969	CcSEcCtD
Octreotide—Pruritus—Topotecan—cervical cancer	0.00239	0.00956	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—AKAP13—cervical cancer	0.00238	0.00424	CbGpPWpGaD
Octreotide—Diarrhoea—Topotecan—cervical cancer	0.00231	0.00924	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—WNT2—cervical cancer	0.00231	0.0041	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AKAP13—cervical cancer	0.00228	0.00406	CbGpPWpGaD
Octreotide—Dizziness—Topotecan—cervical cancer	0.00223	0.00893	CcSEcCtD
Octreotide—Vomiting—Topotecan—cervical cancer	0.00215	0.00859	CcSEcCtD
Octreotide—Rash—Topotecan—cervical cancer	0.00213	0.00852	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—WNT2—cervical cancer	0.00213	0.00379	CbGpPWpGaD
Octreotide—Dermatitis—Topotecan—cervical cancer	0.00213	0.00851	CcSEcCtD
Octreotide—Headache—Topotecan—cervical cancer	0.00211	0.00846	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—WNT5A—cervical cancer	0.00205	0.00366	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AKAP13—cervical cancer	0.00202	0.0036	CbGpPWpGaD
Octreotide—Nausea—Topotecan—cervical cancer	0.002	0.00803	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—WNT5A—cervical cancer	0.00197	0.00351	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOTCH2—cervical cancer	0.0019	0.00339	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AKAP13—cervical cancer	0.00187	0.00332	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—WNT5A—cervical cancer	0.00175	0.00311	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—WNT5A—cervical cancer	0.00161	0.00287	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HES1—cervical cancer	0.00156	0.00278	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH2—cervical cancer	0.00144	0.00257	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH2—cervical cancer	0.00138	0.00246	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TERT—cervical cancer	0.00137	0.00243	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FGFR3—cervical cancer	0.00125	0.00223	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH2—cervical cancer	0.00123	0.00218	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HES1—cervical cancer	0.00118	0.0021	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NOTCH1—cervical cancer	0.00118	0.0021	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HES1—cervical cancer	0.00113	0.00202	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH2—cervical cancer	0.00113	0.00201	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EGFR—cervical cancer	0.00105	0.00187	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TERT—cervical cancer	0.00104	0.00184	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HES1—cervical cancer	0.00101	0.00179	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TERT—cervical cancer	0.000993	0.00177	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGFR3—cervical cancer	0.000951	0.00169	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HES1—cervical cancer	0.000928	0.00165	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGFR3—cervical cancer	0.000912	0.00162	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOTCH1—cervical cancer	0.000893	0.00159	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MTOR—cervical cancer	0.000883	0.00157	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TERT—cervical cancer	0.000881	0.00157	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOTCH1—cervical cancer	0.000856	0.00152	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TERT—cervical cancer	0.000813	0.00145	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CASP3—cervical cancer	0.000812	0.00144	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGFR3—cervical cancer	0.000808	0.00144	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EGFR—cervical cancer	0.000795	0.00142	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CTNNB1—cervical cancer	0.000782	0.00139	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EGFR—cervical cancer	0.000762	0.00136	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOTCH1—cervical cancer	0.000759	0.00135	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR3—cervical cancer	0.000746	0.00133	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOTCH1—cervical cancer	0.0007	0.00125	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—STAT3—cervical cancer	0.000682	0.00121	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EGFR—cervical cancer	0.000676	0.0012	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MTOR—cervical cancer	0.000669	0.00119	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MTOR—cervical cancer	0.000641	0.00114	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EGFR—cervical cancer	0.000624	0.00111	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EGFR—cervical cancer	0.00062	0.0011	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CASP3—cervical cancer	0.000615	0.00109	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CTNNB1—cervical cancer	0.000593	0.00106	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CASP3—cervical cancer	0.00059	0.00105	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MTOR—cervical cancer	0.000569	0.00101	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CTNNB1—cervical cancer	0.000569	0.00101	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MTOR—cervical cancer	0.000525	0.000934	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CASP3—cervical cancer	0.000523	0.000931	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—cervical cancer	0.00052	0.000926	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—STAT3—cervical cancer	0.000517	0.00092	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CTNNB1—cervical cancer	0.000504	0.000897	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—STAT3—cervical cancer	0.000496	0.000882	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CASP3—cervical cancer	0.000483	0.000859	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EGFR—cervical cancer	0.00047	0.000836	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CTNNB1—cervical cancer	0.000465	0.000828	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EGFR—cervical cancer	0.00045	0.000802	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—STAT3—cervical cancer	0.00044	0.000782	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—STAT3—cervical cancer	0.000406	0.000722	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EGFR—cervical cancer	0.000399	0.000711	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—cervical cancer	0.000394	0.000702	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—cervical cancer	0.000378	0.000673	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EGFR—cervical cancer	0.000369	0.000656	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—cervical cancer	0.000335	0.000597	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—cervical cancer	0.00031	0.000551	CbGpPWpGaD
